Molecule to Market: Inside the outsourcing space
By Raman Sehgal
Listen to a podcast, please open Podcast Republic app. Available on Google Play Store and Apple App Store.
Image by Raman Sehgal
Category: Life Sciences
Open in Apple Podcasts
Open RSS feed
Open Website
Rate for this podcast
Subscribers: 4
Reviews: 0
Episodes: 245
Description
Molecule to Market takes you inside the contract outsourcing space with industry insights and thoughts direct from the brains of the people that make the headlines.
Talking everything from pharmaceutical contract research, development and manufacturing to clinical trial packaging, logistics and technology – Molecule to Market is a vital shot of infotainment for anyone who wants in on outsourcing.
| Episode | Date |
|---|---|
|
The CEO leading Ensera's evolution
|
Nov 07, 2025 |
|
CPHI 2025 wrap-up
|
Oct 31, 2025 |
|
20 years of CPHI - Veterans Guide
|
Oct 24, 2025 |
|
Themes from PBOA Conference 2025
|
Oct 21, 2025 |
|
The understated CDMO CCO
|
Oct 17, 2025 |
|
The CEO driving change at Curia
|
Oct 10, 2025 |
|
The People-first CEO of FUJIFILM Biotechnologies
|
Oct 03, 2025 |
|
Driving growth and removing waste for big pharma
|
Sep 26, 2025 |
|
Riding the ups and downs of entrepreneurship
|
Sep 19, 2025 |
|
Unlocking CDMO growth via commercial excellence
|
Sep 12, 2025 |
|
Pharma services market sentiment at the midpoint of 25
|
Sep 05, 2025 |
|
Doc to CEO - 40 years of reinvention in biopharma
|
Aug 29, 2025 |
|
Meet the new boss of CPHI Europe
|
Aug 21, 2025 |
|
30 years on the rollercoaster of clinical trials
|
Aug 15, 2025 |
|
The rain-making, 2X exit founder
|
Aug 08, 2025 |
|
The Indian CEO driving change
|
Aug 01, 2025 |
|
40 years, 6 exits - a CEO addict
|
Jul 25, 2025 |
|
CDMO Live insights: Industry leaders on the future of pharma
|
Jul 18, 2025 |
|
The learning curve of a biotech founder/CSO
|
Jul 11, 2025 |
|
The cancer Doc, driven by impact
|
Jul 04, 2025 |
|
The GM focused on inhaled & nasal drugs
|
Jun 27, 2025 |
|
The impact of a CEO who loves to work
|
Jun 20, 2025 |
|
From brink of bankruptcy to boom
|
Jun 13, 2025 |
|
The CEO addicted to challenge
|
Jun 06, 2025 |
|
The COO leveraging the ‘power of we’
|
May 30, 2025 |
|
The pharma CEO focused on US commercial growth
|
May 23, 2025 |
|
The Spanish solid state specialist
|
May 16, 2025 |
|
The bullish CDMO CEO making bold moves
|
May 09, 2025 |
|
Geordie lad done good in pharma
|
May 02, 2025 |
|
The CEO driven by lentiviral vector success
|
May 02, 2025 |
|
The CRDMO CEO making his luck
|
Apr 18, 2025 |
|
The biotech CEO focused on curing paediatric deafness
|
Apr 11, 2025 |
|
Inside the mind of the CDMO customer
|
Apr 04, 2025 |
|
The master-builder now on a cell therapy crusade
|
Mar 28, 2025 |
|
From astrophysicist to biopharma industry leader
|
Mar 21, 2025 |
|
From Big Pharma to Snapdragon
|
Mar 14, 2025 |
|
The LATAM CRO Queen
|
Mar 07, 2025 |
|
The pulse of Big Pharma CEOs
|
Feb 28, 2025 |
|
How to plan for life sciences events in 2025
|
Feb 21, 2025 |
|
Biopharma Global Supply veteran
|
Feb 14, 2025 |
|
Meet the healthcare futurist
|
Feb 07, 2025 |
|
The dynamic duo driving global growth
|
Jan 31, 2025 |
|
Biopharma Insights: Live from J.P. Morgan
|
Jan 24, 2025 |
|
The CEO making a global impact
|
Jan 17, 2025 |
|
2024 reflections and 2025 outlook in pharma services
|
Jan 10, 2025 |
|
From questions to answers: Celebrating 200 episodes
|
Jan 03, 2025 |
|
Charles River's lifelong CDMO leader
|
Dec 13, 2024 |
|
The pharma ingredients disruptor
|
Dec 06, 2024 |
|
Baking success to IQVIA exit
|
Nov 29, 2024 |
|
The biotech-MedTech CEO tackling obesity
|
Nov 22, 2024 |
|
Delhi boy, done good
|
Nov 15, 2024 |
|
Meet the Top Gun CDMO Maverick
|
Nov 15, 2024 |
|
Tasty Topics: Navigating Novo Nordisk’s Acquisition of Catalent
|
Nov 06, 2024 |
|
Pfizer's retired manufacturing veteran
|
Nov 01, 2024 |
|
Reimagining drug development
|
Oct 18, 2024 |
|
A lifetime of drug hunting
|
Oct 11, 2024 |
|
The pink-haired CEO
|
Oct 04, 2024 |
|
The Harvard spin-out disrupting drug discovery
|
Sep 27, 2024 |
|
The rare disease champion
|
Sep 20, 2024 |
|
The VC Biotech investor
|
Sep 13, 2024 |
|
The diamond in the rough
|
Sep 06, 2024 |
|
One-hour special - The President of the PBOA
|
Aug 30, 2024 |
|
The puzzle-solving CEO
|
Aug 23, 2024 |
|
Summer sentiment: A life science industry check-in & where you'll find me
|
Aug 16, 2024 |
|
Pivoting to partnership success in clinical trial
|
Aug 09, 2024 |
|
A Sterling, CDMO leader
|
Aug 02, 2024 |
|
AI as a force for good in drug development
|
Jul 19, 2024 |
|
Harnessing tech to improve the economics of making medicine
|
Jul 05, 2024 |
|
Tasty Topics: Addressing the potential impact of the BIOSECURE Act
|
Jun 28, 2024 |
|
Becoming...a world class scientific leader
|
Jun 21, 2024 |
|
Mission-driven doctor, inventor & entrepreneur
|
Jun 13, 2024 |
|
The boomerang boy impacting gene therapies
|
Jun 07, 2024 |
|
Taking on the biologics CDMOs from down under
|
May 31, 2024 |
|
A true nerd of CGT
|
May 24, 2024 |
|
The virtual and decentralized clinical trials specialists
|
May 17, 2024 |
|
Jumping into CDMO after a lifetime as a sponsor
|
May 10, 2024 |
|
Zero to a billion... A CDMO original - part 2
|
May 03, 2024 |
|
Zero to a billion... A CDMO original - part 1
|
Apr 26, 2024 |
|
Dan’s the man...at Custom Biologics
|
Apr 19, 2024 |
|
Celebrating female talent in life sciences
|
Apr 05, 2024 |
|
The power of peptides
|
Mar 28, 2024 |
|
From Pfizer to CDMO carve-out
|
Mar 22, 2024 |
|
One-hour special: Meet the next big thing in obesity
|
Mar 15, 2024 |
|
M&A Roundtable and 2024 Predictions
|
Mar 08, 2024 |
|
Transforming a family pharma firm
|
Mar 01, 2024 |
|
From MassBio... to the world
|
Feb 23, 2024 |
|
From banking to biotech
|
Feb 16, 2024 |
|
Dealing with downturns... and the menopause.
|
Feb 09, 2024 |
|
The dealmaker now redefining commercialization
|
Feb 02, 2024 |
|
The biotech CDMO planning to impact the US
|
Jan 26, 2024 |
|
Molecule to Market: Our top trends 2023; part 2
|
Jan 19, 2024 |
|
Outsourcing in Ontario - on the cusp of greatness
|
Jan 12, 2024 |
|
Discover Diana of Dalriada
|
Jan 05, 2024 |
|
Molecule to Market: Our top trends 2023, part 1
|
Dec 29, 2023 |
|
Expert to Entrepreneur
|
Dec 15, 2023 |
|
The lab model of the future?
|
Dec 08, 2023 |
|
Look into 2024: Events Roundtable special
|
Dec 01, 2023 |
|
The problem-solving CMC consultant
|
Nov 24, 2023 |
|
Microsoft talks to Molecule to Market
|
Nov 17, 2023 |
|
Biopharma innovation in motion
|
Nov 10, 2023 |
|
Say hello to a “CTDMO”
|
Nov 03, 2023 |
|
The involuntary entrepreneur chemist
|
Oct 27, 2023 |
|
A passion for pharma packaging
|
Oct 20, 2023 |
|
M2M meets Moderna & CPHI Conversations
|
Oct 17, 2023 |
|
Launching a technology-forward CDMO
|
Oct 13, 2023 |
|
Designing facilities today for tomorrow’s medicines
|
Oct 06, 2023 |
|
The problem-solving biopharma veteran
|
Sep 29, 2023 |
|
The servant leader creating the next generation CDMO
|
Sep 22, 2023 |
|
From Powdersize to Microsize
|
Sep 15, 2023 |
|
The mission-driven biotech CEO
|
Sep 08, 2023 |
|
Foot on the pedal for Predictive Oncology
|
Sep 01, 2023 |
|
One-hour special: The biopharma outsourcer
|
Aug 25, 2023 |
|
From rural roots to global pharma leader
|
Aug 18, 2023 |
|
Igniting biotech innovation
|
Aug 11, 2023 |
|
From CDMO exit to CDMO+
|
Aug 04, 2023 |
|
From MBO to global, family-run CRO
|
Jul 28, 2023 |
|
Attracting and retaining the best talent; a roundtable special
|
Jul 21, 2023 |
|
Breathing life into high potential medicines
|
Jul 14, 2023 |
|
Molecule to Market is on the move...
|
Jul 12, 2023 |
|
Barbara’s journey into Biopharma
|
Jul 07, 2023 |
|
The CDMO CEO that doesn’t sugarcoat
|
Jun 30, 2023 |
|
Wheeler CDMO Avengers...assemble!
|
Jun 23, 2023 |
|
The future is bright, the future is CGT
|
Jun 16, 2023 |
|
The biopharma boss on a mission against mental health disorders
|
Jun 09, 2023 |
|
From semiconductors to life sciences
|
Jun 02, 2023 |
|
The CRO scientist turned entrepreneur
|
May 26, 2023 |
|
CDMO poacher turned biotech gamekeeper
|
May 19, 2023 |
|
Q123 M&A roundtable
|
May 12, 2023 |
|
Meet the future of bioreactors
|
May 05, 2023 |
|
Meet the lean, keen biotech
|
Apr 28, 2023 |
|
Why biotechs are feeling the bite
|
Apr 21, 2023 |
|
The Amalgamator of Biz and Bio
|
Apr 14, 2023 |
|
The 30-year biotech and CDMO entrepreneur
|
Apr 06, 2023 |
|
The ATMP and CDMO deal maker
|
Mar 31, 2023 |
|
From AZ to CRO Founder
|
Mar 24, 2023 |
|
The iterative nature of emerging therapeutics
|
Mar 17, 2023 |
|
Think Star Trek, Think Smart Labs
|
Mar 10, 2023 |
|
Founding and selling three bio CDMOs - Part 2
|
Mar 03, 2023 |
|
Founding and selling three bio CDMOs - Part 1
|
Feb 24, 2023 |
|
Network like a pro
|
Feb 17, 2023 |
|
Diversity in life sciences
|
Feb 10, 2023 |
|
The CDMO CEO on the frontline of a Covid mission
|
Feb 03, 2023 |
|
Industry insights you cannot afford to miss
|
Jan 27, 2023 |
|
The Puzzle-Solving Lifelong Science Geek
|
Jan 20, 2023 |
|
The CDMO with a capital D
|
Jan 13, 2023 |
|
100 episodes of Molecule to Market: looking back, lessons & laying the land for 101
|
Jan 06, 2023 |
|
Raman’s review of life science in 2022
|
Dec 29, 2022 |
|
A blast from the life science past
|
Dec 23, 2022 |
|
Tackling the 3 Big C’s: CDMO Career, Children & Cancer
|
Dec 16, 2022 |
|
Mystic Miller’s review of ’22 and predictions for ’23
|
Dec 09, 2022 |
|
Top 5 episodes of all time
|
Nov 18, 2022 |
|
CPHI 2022 - Trends, challenges & opportunities
|
Nov 11, 2022 |
|
Views from AAPS 2022
|
Oct 28, 2022 |
|
The Personalized Medicine Pioneer
|
Oct 21, 2022 |
|
Inizio’s biotech bromance
|
Oct 06, 2022 |
|
The Magic of Drug Development
|
Sep 29, 2022 |
|
Why everything starts with great culture
|
Sep 08, 2022 |
|
The orphan drug entrepreneur
|
Aug 12, 2022 |
|
The wonder of Wurster technology
|
Jul 22, 2022 |
|
Biotech trends you need to know
|
Jul 15, 2022 |
|
Biotech briefs
|
Jul 08, 2022 |
|
Africa’s biotech butterfly
|
Jun 27, 2022 |
|
The global pharma leader with an eye on societal impact
|
Jun 20, 2022 |
|
From PhD to Pioneer
|
Jun 17, 2022 |
|
Supply chain challenges and trends
|
Jun 10, 2022 |
|
Chats from CPhI North America
|
May 27, 2022 |
|
The BioPharmGuy
|
May 16, 2022 |
|
Chronicles of Swiss Biotech day
|
May 11, 2022 |
|
From CDMO builder to CDMO creator
|
May 04, 2022 |
|
Built in Boston, now rebuilding businesses
|
Apr 25, 2022 |
|
In the trenches of pharma manufacturing
|
Apr 22, 2022 |
|
From Sweden with Science
|
Apr 11, 2022 |
|
The niche, niche CDMO with enviable patient reach
|
Apr 06, 2022 |
|
Diaries of DCAT
|
Apr 06, 2022 |
|
Finland’s Viral Vector Manufacturer of Happinesses
|
Mar 01, 2022 |
|
From corporate rebel to CDMO entrepreneur
|
Feb 25, 2022 |
|
Mr digital transformation
|
Feb 17, 2022 |
|
The Latin American logistics leader
|
Feb 09, 2022 |
|
The opportunistic entrepreneur
|
Jan 31, 2022 |
|
The Floundering Founder, a lifetime of knowledge for as little as a pound/dollar.
|
Jan 25, 2022 |
|
From Pharmacy to $1B family-owned CDMO
|
Jan 24, 2022 |
|
Roundtable: M&A trends in CDMO
|
Jan 18, 2022 |
|
The UK’s hidden life science gem
|
Jan 10, 2022 |
|
Meet the potent powder expert
|
Dec 20, 2021 |
|
Physician. Scientist. Entrepreneur.
|
Dec 15, 2021 |
|
Hollywood DVDs to biotech drugs
|
Dec 10, 2021 |
|
The big pharma sourcing specialist
|
Nov 29, 2021 |
|
The Cleanroom Veteran
|
Nov 18, 2021 |
|
The 4Cs every CDMO vendor should know
|
Nov 15, 2021 |
|
What next for trade events?
|
Oct 15, 2021 |
|
The life science dating agent
|
Oct 04, 2021 |
|
A little, big announcement...
|
Sep 16, 2021 |
|
The CDMO start-up... with a heck of a track record
|
Sep 03, 2021 |
|
From Big Pharma to CDMO leader
|
Aug 12, 2021 |
|
The change optimist
|
Jul 15, 2021 |
|
The Public Health vaccine specialist
|
Jul 08, 2021 |
|
The academic turned biopharma innovator
|
Jun 30, 2021 |
|
From chemist to consultant
|
Jun 25, 2021 |
|
The unique general
|
May 20, 2021 |
|
The Stickability factor
|
May 12, 2021 |
|
Poacher turned gamekeeper, turned hybrid
|
Apr 30, 2021 |
|
The humble leader
|
Apr 21, 2021 |
|
The understated, elite vaccine scientist
|
Apr 14, 2021 |
|
Creating a healthy culture
|
Apr 01, 2021 |
|
40 at 40
|
Mar 25, 2021 |
|
From Pfizer to CDMO start-up
|
Mar 17, 2021 |
|
Expanding drug dosage possibilities…
|
Mar 10, 2021 |
|
From Teesside Uni to global leader
|
Mar 03, 2021 |
|
The accidental CDMO
|
Feb 22, 2021 |
|
The passionate problem solver
|
Feb 15, 2021 |
|
The entrepreneurial scientist
|
Feb 08, 2021 |
|
The sales guru
|
Jan 28, 2021 |
|
Marathons. Wine. And 30 years in healthcare.
|
Jan 21, 2021 |
|
The industry guru
|
Jan 14, 2021 |
|
10 Trends for 2021
|
Jan 08, 2021 |
|
The CDMO Disrupter
|
Dec 10, 2020 |
|
The biologic CDMO growth guy
|
Nov 24, 2020 |
|
Leading M&A at a top-5 global CDMO
|
Nov 20, 2020 |
|
The virotherapy virtuoso
|
Nov 13, 2020 |
|
Roundtable: Collaboration and driving efficiency
|
Oct 16, 2020 |
|
Roundtable: Latest trends in CDMO
|
Oct 15, 2020 |
|
Roundtable: Clinical trials in 2020 and beyond
|
Oct 15, 2020 |
|
Roundtable: Global geography and the pharma and bio supply chain
|
Oct 13, 2020 |
|
Scientist & champion powerlifter
|
Sep 29, 2020 |
|
From fax to SaaS: digitising the the pharma supply chain
|
Sep 22, 2020 |
|
Successful outsourcing partnerships: now and then
|
Sep 08, 2020 |
|
Old world solutions won’t work for new world problems
|
Aug 31, 2020 |
|
Looking towards the future: A continuous mindset
|
Aug 25, 2020 |
|
Life in a boutique, specialist CDMO
|
Aug 10, 2020 |
|
Owning your authenticity
|
Aug 03, 2020 |
|
Building robust and scalable systems
|
Jul 27, 2020 |
|
Entrepreneurship in the life science space
|
Jul 22, 2020 |
|
Advocating for the CDMO sector
|
Jul 20, 2020 |
|
The benefits of postponement packaging
|
Jul 15, 2020 |
|
Taking the family-owned CDMO global
|
Jul 13, 2020 |
|
The increasing demand for HPAPI
|
Jul 06, 2020 |
|
A CDMO on the Covid-19 frontline
|
Jul 01, 2020 |
|
Learnings from 30 years in the CDMO space
|
Jun 17, 2020 |
|
The importance of positive, disruptive thinking
|
Jun 15, 2020 |
|
The value of diversity In pharma
|
Jun 11, 2020 |
|
Life as a journalist in the space
|
May 20, 2020 |
|
What is driving the demand for spray drying?
|
May 20, 2020 |
|
A Generation of Pharma Entrepreneurs
|
May 20, 2020 |
|
Leading a top tier CDMO
|
May 20, 2020 |
|
Intro to molecule to market
|
Apr 20, 2020 |